Sterling Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.4K Buy
2,442
+1,675
+218% +$6.11K ﹤0.01% 2257
2026
Q1
$3.03K Sell
767
-19
-2% -$96 ﹤0.01% 2891
2025
Q4
$5.32K Buy
786
+499
+174% +$3.5K ﹤0.01% 2875
2025
Q3
$2K Buy
287
+1
+0.3% +$7 ﹤0.01% 2976
2025
Q2
$1.75K Sell
286
-850
-75% -$5.65K ﹤0.01% 2949
2025
Q1
$8.63K Sell
1,136
-923
-45% -$7.71K ﹤0.01% 1917
2024
Q4
$19.8K Buy
2,059
+1,782
+643% +$13.9K ﹤0.01% 1876
2024
Q3
$1.64K Buy
+277
New +$1.83K ﹤0.01% 2277

Other funds holding MDXG

Sterling Capital Management's MDXG Position: Q2 2026 in Review

Sterling Capital Management increased its MiMedx Group (MDXG) stake by 218% in Q2 2026, buying an estimated $6.11K and bringing the position to 2,442 shares worth $9.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Sterling Capital Management first reported a position in MDXG in Q3 2024 and has held it in 8 quarters since. The position peaked at $19.8K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Sterling Capital Management held 2,442 shares of MiMedx Group worth $9.4K as of Q2 2026.
  • Sterling Capital Management bought 1,675 MiMedx Group shares in Q2 2026, an estimated $6.11K.
  • MiMedx Group made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2257 holding.
  • Sterling Capital Management first reported a position in MiMedx Group in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's MiMedx Group position peaked at $19.8K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.